DiA Imaging Analysis Ltd, announced today a multi-year agreement with Change Healthcare. Change Healthcare’s proven cardiology solutions, along with DiA’s AI-based algorithms, will benefit echocardiologists and other imaging specialists by improving the efficiency of routine tasks and the effectiveness of workflow in the Echo Lab reading environment, according to the press release.
Under the agreement, DiA’s US Food and Drug Administration (FDA)-cleared and CE-marked LVivo Seamless solution, an AI-based software for cardiac ultrasound, will be available on Change Healthcare’s imaging solutions in Echo Labs.
The evaluation of cardiac ultrasound images typically involves eyeballing and manual steps. Variability across readers’ interpretation may be influenced by external factors, such as experience and training background. DiA’s AI-based LVivo Seamless solution automates the workflow and automatically selects and analyses the optimal cardiac images, generating key clinical indications of both left and right ventricle function.
“For artificial intelligence to be truly valuable, it must be integrated into the clinician’s daily routine and readflow,” said Hila Goldman Aslan, CEO, and co-founder of DiA. “Our team at DiA Imaging Analysis is excited to be working with Change Healthcare, making our AI-based software accessible to echocardiologists and sonographers around the world.”
